African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12486

Full Length Research Paper

In vitro dilutions of thioridaxine with potential to enhance antibiotic sensitivity in a multidrug resistant Staphylococcus aureus uropathogen

Otajevwo, F. D.
  • Otajevwo, F. D.
  • Department of Microbiology and Biotechnology, Western Delta University, Oghara, Delta State, Nigeria.
  • Google Scholar


  •  Received: 03 January 2014
  •  Accepted: 19 February 2015
  •  Published: 04 March 2015

References

Akortha EE, Aluyi HAS, Enerijiofi KE (2011). Transfer of amoxicillin resistance gene among bacteria isolates from sputum of pneumonia patients attending the University of Benin Teaching Hospital, Benin City, Nigeria. J. Med. Sci. 2(7):1003-1009.

 

Akortha EE, Filgona J (2009). Transfer of gentamicin resistance genes among enterobacteriaceae isolated from the outpatients with urinary tract infections attending three hospitals in Mubi, Adamawa State. Sci. Res. Essay 4(8):745-752.

 
 

Amara L, Spendler G, Martins A, Molnar J (2013). Efflux pumps that bestow multidrug resistance of pathogenic gram negative bacteria. Biochem. Pharmacol. J. 2(3):119-121.

 
 

Barth VN, Charnet E, Martin LJ, Need AB (2006). Comparison of rat dopamine D2 receptor occupancy for a series of anti-psychotic drugs like thioridaxine. Life Sci., 78(26):3007-3019.
Crossref

 
 

Bhalakia N (2008). Isolated and plasmid analysis of vancomycin resistant Staph. aureus. J. Young Investigators. 18:1-5.

 
 

Bauer AW, Kirby WMM, Sherris JC, Turk M (1966). Antibiotic susceptibility testing by a standardized single disc method. Am.J.Clin. Pathol. 45:493-496.
Pubmed

 
 

Byron F, Brehm S, Eric AJ (2003). Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by these sesquiterpenoids. Antimicrob. Agents Chemother. 47(10):3357-3360.
Crossref

 
 

Chakrabarthy PK, Mishra AK, Chakrabarti SK (1984). Loss of plasmid-like drug resistance after treatment with iodo-deoxyuridine. Indian J. Expt. Biol. 22: 333-334.

 
 

Crowle AJ, Douvas SG, May MH (1992). Chlorpromazine: a drug potentially useful for treating Mycobacterial infections. Chemotherapy 38:410-419.
Crossref

 
 

Diekema DJ, Pfaller MA, Schmitz FJ (2001). Survey of infections due to Staphylococcus spp: Frequency occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY antimicrobial surveillance programme. Clin. Infect. Dis. 32(2):5114-5132.

 
 

Dimitru G, Poiata A, Tuchilus C, Buiuc D (2006). Correlation between linezolid zone diameter and minimum inhibitory concentration valves determined by regression analysis. Rev. Med. Chir. Soc. 110(4):1016-1025.

 
 

Gomber C, Saxena S (2007). Anti-Staphylococcal potential of callistemon rigidus. Cent. Eur. J. Med. 2:79-88.
Crossref

 
 

Gupta TD, Bandyopathy T, Dastidar SG, Bandopadhyay M, Mistra A, Chakrabarty AN (1980). R- plasmids of Staphylococci and their elimination by different agents. Indian J. Expt. Biol. 18:478-481.
Pubmed

 
 

Jan MB, John DT, Sentry P (2004). High prevalence of oxacillin resistant Staph aureus isolates from hospitalized patients in Asia-Pacific and South Africa: Results from SENTRY antimicrobial surveillance program. 1998-1999. Antimicrob. Agent Chemother. 46:879-881.

 
 

Lakshmi VV, Padma S, Polasa H (1989). Loss of plasmid antibiotic resistance in Escherichia coli on treatment with some compounds. FEMS Microbiol. Letts. 57:275-278
Crossref

 
 

Kohler NO (2010). Non- antibiotics Reverse Resistance of Bacteria to Antibiotics in vivo. J. Antimicrob. Chemother. 24(5):751-754.

 
 

Madigan M, Martinko J, Parker J (2003). Brock Biology of Microorganisms (10th edn). Prentice Hall, Upper Saddle River, NJ., USA. 500p.

 
 

Mbata TI (2007). Prevalence and antibiogram of UTI among prisons Inmates in Nigeria Inter. J. Microbiol. 3(2):10-15.

 
 

McGowan JE (2006). Resistance in non-fermenting gram negative bacteria: multidrug resistance to the maximum. Am. J. Infect. Control 34:29-37.
Crossref

 
 

McGowan AP, Wise R (2001). Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J. Antimicrob. Chemother. 48:17-28.
Crossref

 
 

Mukherjee S, Chaki S, Das S, Sen S, Datta SK, Dastidar SG (2011). Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa. Indian J. Exp. Biol. 49:447-551.

 
 

Mukherjee S, Chaki S, Barman S, Das H, Koley, Dastidar SG (2012). Effective elimination of drug resistance genes in pathogenic Pseudomonas aeruginosa by an antipsychotic agent–thioridaxine. Curr. Res. Bacteriol. 5:36-41.
Crossref

 
 

Namita J, Pushpa S, Lalit S (2012). Control of multidrug resistant bacteria in a tertiary care hospital in India. Antimicrob. Resistance & Infection Control. 1:23-30.
Crossref

 
 

NCCLS (2000). Methods for dilution, Antimicrobial Susceptibility Tests for bacteria that grow aerobically. Approved Standard (5th edition). Wayne, PA, USA.

 
 

Neu HC (1989). Overview of mechanisms of bacterial resistance. Diagnost. Microbiol. Infect. Dis. 12:109-116.
Crossref

 
 

Obaseki-Ebor EE (1984). Rifampicin curing of plasmids in Escherichia coli K12 rifampicin resistant host. J. Pharm. Pharmacol. 36: 467-470.
Crossref

 
 

Ochei J, Kolhhatkar A (2008). Medical Laboratory: Theory and practice, 10th edition. New Delhi: Tata McGraw-Hill Publishing Company. 1338p.

 
 

Okeke IN, Lamikanra A, Edelman R (1999). Socio-economic and behavioural factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg. Infect. Dis. 5:18-27.
Crossref

 
 

Oluremi BB, Idowu AO, Olaniyi JF (2011). Antibiotic susceptibility of common bacterial pathogens in urinary tract infections in a Teaching Hospital in Southwestern Nigeria. Afr. J. Microbiol. Res. 5(22):3658-3663.
Crossref

 
 

Oskay M, Oskay D, Kalyoneu F (2009). Activity of some plant extracts against multidrug resistant human pathogens. Iranian J. Pharm. Res. 8(4): 293-300.

 
 

Otajevwo FD, Momoh SA (2013). Resistance marker loss of multi-drug resistant (MDR) Staphylococcus aureus strains after treatment with dilutions of acridine orange. J. Med. Med. Sci. 2(2):43-62. ISSN: 2241-2328.

 
 

Otajevwo FD, Okungbowa A (2014). A study on resistance loss of multidrug resistant (MDR) Pseudomonas aeruginosa strains after treatment with dilutions of acrdine orange. Intl. J. Med. Med. Sci. 6(1):24-33.
Crossref

 
 

Otajevwo FD. (2012). Sensitivity enhancement of multidrug resistant urinary tract Escherichia coli isolate to some commonly used Antibiotics after treatment with non-toxic laboratory concentrations of homodium bromide. IOSR J. Pharm. 2(3): 540-568

 
 

Ramesh A, Halami PM, Chandrasekhar A (2000). Ascorbic acid induced loss of a pediocin-encoding plasmid in Pediococcus acidilactici CFR K7. World J. Microbiol. Bio. 16:695-697.
Crossref

 
 

Reddy G, Shridhar P, Polasa H (1986). Elimination of Col. E1 (pBR322 and pBR329) plasmids in Escherichia coli on treatment with hexamine ruthenium III chloride. Curr. Microbiol. 13: 243-246.
Crossref

 
 

Shiram V, Jahagirdar S, Latha C, Kumar V, Puranik V, Rojatkar S (2008). A potential plasmid curing agent, 8-epidiosbulbin E acetate from Dioscorea bulbifera L against multidrug resistant bacteria. Intl. J. Antimicrob. Agents. 32(5): 405-410
Crossref

 
 

Stanier RY, Adelberg EA, Ingraham JL (1984). General Microbiology, 4th edn. The Macmillan Press Ltd, Basingstoke London.

 
 

Trevors JT (1986). Plasmid curing in bacteria. FEMS Microbiol. Rev. 32(3):149-157.
Crossref

 
 

Viveiros M, Jesus A, Brito M, Leandro C, Martins M. (2010). Inducement and reversal of tetracycline resistance in Escherichia coli K12 and expression of proton gradient-dependent multidrug efflux pumps genes. Antimicrob. Agents Chemother. 49:3578-3582.
Crossref

 
 

Woo PCY, Lau, SKP, Yeun KY (2003). Facilitation of horizontal transfer of antimicrobial resistance by transformation of antibiotic-induced cell wall- deficient bacteria. Med. Hypot. 61(4):503-508.
Crossref

 
 

World Health Organization. (2012). Antimicrobial resistance in the European Union and the World. Lecture delivered by Dr Margaret Chan, Director-General of WHO at the Conference on combating antimicrobial resistance: time for action. Copenhagen, Denmark, March 14th, 2012.